The results of a Phase 3 trial show that Eli Lilly’s Alzheimer’s drug, donanemab, can significantly slow down functional decline.
Parkinson's disease (PD) is a recognisable clinical syndrome that represents a fast-growing neurodegenerative condition and there is a worldwide rising prevalence. This article highlights the recent updates in the diagnosis and management.
A new treatment for Alzheimer’s disease is able to safely and successfully lower levels of tau – a protein predominantly found in brain cells that is thought to be a cause of the disease.
Around 145,000 people live with Parkinson’s disease in the UK and it is the fastest growing neurological condition in the world. This article is an overview of diagnosis and current treatment options.
Identifying an abnormal build-up of protein deposits on the brain could help to catch Parkinson’s disease early, according to the largest study to date, published in The Lancet Neurology journal.
Parkinson’s UK has launched its first equality, diversity and inclusion (EDI) strategy, which aims to better support people with Parkinson’s to access services and improve representation in research.
Public awareness about dementia’s far-reaching impact on society is “poor”, according to a new survey of more than 2,000 people.
In this article, we speak to two leading neurologists and a patient about neuromyelitis optica spectrum disorder (NMOSD); a rare autoimmune disorder, predominantly affecting young women, which causes inflammation of the optic nerves and…
Drugs used to treat type 2 diabetes could reduce the risk of dementia, according to a long-term study published in the journal BMJ Open Diabetes Research & Care.
People who are diagnosed with early onset dementia are nearly seven times more likely to take their own life, according to new UK study.
NICE has conditionally recommended five wearable devices for patients with Parkinson’s disease, which will enable the NHS to better collect data on patients’ symptoms.
A new drug has been found to slow the course of Alzheimer’s disease by reducing the speed at which patients’ memory and thinking declines.
Epilepsy is more common in older people, but diagnosis can be delayed by atypical presentation and non-specific symptoms. Mood problems such as depression and anxiety are also common and treatment may have a greater impact on quality of…
Older adults may be able to slow cognitive decline by taking daily multivitamin supplements, according to a large US study.
People with worse cardiovascular disease and increased cerebrovascular disease at the age of 36 have a higher brain age later in life, according to new research.